Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin and Metformin in Type 2 Diabetes
NCT00820573Phase 4Completed
- Sponsor
- UT Health San Antonio
- Start
- Oct 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin, liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by UT Health San Antonio. Started Oct 2009; status: completed.
02
Drugs
sitagliptinliquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00820573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00820573.